EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma

Схожие документы

• Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment
  по: Kuiper, J L, et al.
  Опубликовано: (2016)
• EGFR Mutations and Lung Cancer
  Опубликовано: (2005)
• Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression
  по: van der Wekken, A. J., et al.
  Опубликовано: (2017)
• Advances on EGFR mutation for lung cancer
  по: Metro, Giulio, et al.
  Опубликовано: (2012)
• EGFR unusual mutation status in lung adenocarcinomas
  по: Alarcão, Ana, et al.
  Опубликовано: (2010)